1. Home
  2. LZB vs NEO Comparison

LZB vs NEO Comparison

Compare LZB & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$38.78

Market Cap

1.6B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
NEO
Founded
1927
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
LZB
NEO
Price
$38.78
$11.44
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$42.50
$11.38
AVG Volume (30 Days)
394.6K
1.9M
Earning Date
02-17-2026
02-17-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
N/A
EPS
2.16
N/A
Revenue
$2,107,357,000.00
$709,162,000.00
Revenue This Year
$2.36
$10.86
Revenue Next Year
$3.57
$9.70
P/E Ratio
$17.97
N/A
Revenue Growth
1.78
10.10
52 Week Low
$29.03
$4.72
52 Week High
$48.13
$14.73

Technical Indicators

Market Signals
Indicator
LZB
NEO
Relative Strength Index (RSI) 52.93 37.64
Support Level $35.76 $11.24
Resistance Level $39.03 $12.68
Average True Range (ATR) 0.95 0.51
MACD 0.02 -0.18
Stochastic Oscillator 61.97 5.85

Price Performance

Historical Comparison
LZB
NEO

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: